Methylphenidate in Childhood Apraxia of Speech

NCT05185583 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Childhood Apraxia of Speech

Interventions

DRUG: Methylphenidate Hydrochloride
DRUG: Placebo

Sponsor

Murdoch Childrens Research Institute